Related Experiment Video
Updated: Sep 30, 2026

Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI
Published on: April 18, 2011
Serotonin agents in the treatment of acquired brain injury
Ross D Zafonte1, Nora Cullen, Jan Lexell
1Department of Physical Medicine and Rehabilitation, University of Pittsburgh, 3471 Fifth Avenue, Pittsburgh, PA 15213, USA. zafonterd@msx.upmc.edu
Background:
The development of novel serotonin agents has led to an increased use of these medications throughout medical practice. An understanding of the basic pharmacological function of these agents is key to understanding their usefulness. Among persons with brain injury, serotonin agents have been used for the treatment of depression, panic disorder, obsessive-compulsive disorders, agitation, sleep disorders, and motor dysfunction.
Conclusion:
This article will review the mechanisms, efficacy, and side effects of serotonin agents with a focus on persons with brain injury.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Traumatic Brain Injury l: Introduction
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Alzheimer's Disease: Treatment